MedDeviceGuideMedDeviceGuide
Back

Reprocessing Instructions in Medical Device IFUs: How to Write User-Friendly, Validated, Audit-Ready Instructions

Step-by-step guide to writing reprocessing instructions for reusable medical device IFUs — covering point-of-use treatment, cleaning, disinfection, sterilization, drying, storage, reuse life claims, warnings, usability validation, and audit readiness per FDA guidance, ISO 17664, and ISO 20417.

Ran Chen
Ran Chen
Global MedTech Expert | 10× MedTech Global Access
2026-04-3014 min read

Why IFU Quality Is a Regulatory Flashpoint

Reprocessing instructions are among the most scrutinized sections of any reusable medical device labeling. FDA's 2015 final guidance on reprocessing was triggered in part by highly publicized hospital-acquired infection outbreaks linked to inadequate duodenoscope IFUs. Since then, FDA has consistently treated reprocessing instructions as a submission-acceptance issue — not just a labeling detail. In the EU, notified bodies audit IFU completeness against ISO 17664-1:2021 as a routine part of technical documentation review.

A well-written IFU protects patients, supports regulatory clearance, and reduces post-market complaints. A poorly written one invites Refuse-to-Accept (RTA) decisions, additional information requests, and field safety corrective actions.

This guide covers what to write, how to structure it, how to validate it, and how to prepare it for audit.

Applicable Standards and Regulatory References

Standard / Regulation What It Requires
ISO 17664-1:2021 Specifies information manufacturers must provide for processing critical and semi-critical devices
ISO 17664-2:2021 Same as above, for non-critical devices
FDA Guidance (March 2015) Reprocessing Medical Devices in Health Care Settings — validation methods and labeling
ISO 20417:2026 Updated medical device labeling requirements, including measurable IFU readability for lay users
ANSI/AAMI ST98:2022 Cleaning validation standard supporting the IFU cleaning section
21 CFR 801 General device labeling requirements
EU MDR Annex I, Chapter III Requirements for information supplied with the device
Implementing Regulation (EU) 2021/2226 Electronic IFU (eIFU) requirements, updated by (EU) 2025/1234 for 2026

Spaulding Classification: The Starting Point for Every IFU

The Spaulding classification determines the minimum reprocessing method required and should be stated explicitly in the IFU. FDA's 2015 guidance reinforces this as a foundational decision.

Classification Definition Minimum Reprocessing Example Devices
Critical Contacts sterile tissue or vascular system Sterilization required Surgical instruments, implants, cardiac catheters, arthroscopes
Semi-critical Contacts mucous membranes or non-intact skin High-level disinfection minimum; sterilization preferred Endoscopes, laryngoscope blades, respiratory therapy equipment
Non-critical Contacts intact skin only Low- or intermediate-level disinfection Stethoscopes, blood pressure cuffs, bedpans, wheelchairs

The IFU must specify the reprocessing method consistent with the device's Spaulding classification and the validation must support it.

Recommended Reading
ISO 17664 Reprocessing Validation for Reusable Medical Devices: Standards, FDA Expectations, and Submission Evidence
Quality Systems Regulatory2026-04-30 · 12 min read

The Six Essential Sections of Reprocessing IFUs

FDA's 2015 guidance and ISO 17664-1 converge on a common set of required information. Below is the recommended structure with detailed content guidance for each section.

Section 1: Device Identification and Scope

Purpose: Ensure the user can confirm they have the correct instructions for their device.

Required Content Detail Level
Device trade name and model/catalog number Exact match to device labeling
Applicable accessories and components List all components that require reprocessing
Device classification (critical / semi-critical / non-critical) Per Spaulding classification; drives disinfection/sterilization method
Intended reprocessing life (number of cycles) Must match validation data
Contraindications for reuse Conditions under which the device must not be reprocessed

Common deficiency: Omitting the maximum number of reprocessing cycles, or stating a number not supported by end-of-life testing.

Section 2: Point-of-Use Treatment

Purpose: Prevent soil from drying on the device before it reaches the reprocessing area.

Required Content Example Language
Initial action at point of use "Immediately after use, wipe external surfaces with a damp cloth to remove visible soil."
Moisture maintenance "Keep device moist by covering with a damp towel or placing in a moisture-retaining transport container."
Maximum delay before cleaning "Do not allow soil to dry on the device. Begin cleaning within 60 minutes of use."
Disassembly instructions "Disassemble the device into its three component parts (handle, shaft, tip) by rotating the locking collar counterclockwise."
Transport to reprocessing area "Place disassembled components in a closed, leak-proof container for transport to the decontamination area."

FDA emphasis: Delays between use and reprocessing create conditions favorable to microbial growth and increase the challenge to subsequent cleaning and disinfection/sterilization steps. The 2015 guidance specifically calls for "prompt, initial cleaning steps and/or measures to prevent the drying of soil."

Section 3: Preparation for Cleaning

Required Content Notes
Disassembly instructions with illustrations Show each step; identify components by name
Removal of single-use accessories Specify which parts are discarded, not reprocessed
Pre-rinse instructions Duration, water type, and method
Soaking instructions (if applicable) Solution, concentration, temperature, duration

Section 4: Cleaning

This section must describe the validated cleaning method — manual, automated, or both.

For Manual Cleaning:

Element Content to Include
Detergent Brand name, product name, concentration, and where to obtain
Water quality and temperature E.g., "Reverse osmosis water at 20–40 °C"
Soaking Duration and conditions
Brushing Brush type, size, strokes per surface, direction
Lumen flushing Volume, syringe/flushing device type, number of flushes
Rinsing Volume, water quality, duration
Inspection Visual inspection criteria, lighting requirements
Personal protective equipment PPE requirements for reprocessing personnel

For Automated Cleaning (Washer-Disinfector):

Element Content to Include
WD make and model (or compatible class) Specific validated machine or performance class
Cycle program name/number Exact cycle to select
Detergent Brand, product, concentration, dosing method
Rinse aid (if applicable) Brand, concentration
Load configuration How to arrange instruments in carriers; reference to loading diagram
Connection of lumened devices Adapter type, connection method
Post-cycle inspection Visual inspection after WD cycle completes

Critical point: If both manual and automated methods are offered, each must have been separately validated. Do not imply that one method is validated based on the other's evidence.

Section 5: Disinfection or Sterilization

Disinfection:

Element Content to Include
Disinfection method High-level disinfection (HLD) or intermediate/low-level as justified
Agent (if chemical) Brand name, concentration, contact time, temperature
Automated parameters (if thermal WD) A₀ value, temperature, time
Rinsing after chemical disinfection Volume, method, water quality
Drying Method and duration

Sterilization:

Element Content to Include
Sterilization method Steam, EO, hydrogen peroxide vapor, etc.
Cycle parameters Temperature, exposure time, dry time
Packaging Type, configuration, how to arrange in sterilizer
Biological indicator Type and placement (for validation reference)
Sterility Assurance Level (SAL) Typically 10⁻⁶
Post-sterilization dry time Duration, conditions

Section 6: Storage and Reuse

Element Content to Include
Storage conditions Temperature, humidity, shelf life after sterilization
Packaging integrity check How to verify before use
Reuse life limit Maximum number of reprocessing cycles; how to track
Functional check before use What the user must verify before each patient use
Disposal instructions When and how to discard the device

Warnings and Precautions

IFUs must include specific warnings that address foreseeable misuse. Common required warnings:

Warning Category Example
Incomplete reprocessing risk "Failure to follow all reprocessing instructions may result in retained organic material or microbial contamination, potentially causing patient infection."
Device damage "Do not use abrasives, wire brushes, or ultrasonic cleaning unless specified. These may damage the device coating."
Chemical safety "Wear appropriate PPE when handling cleaning and disinfecting agents. Refer to agent Safety Data Sheet."
Reuse limit "Do not exceed [X] reprocessing cycles. Device performance beyond this limit has not been validated."
Single-use components "The [component name] is single-use only. Do not reprocess."
Compatibility "Use only the specified cleaning agents and sterilization methods. Use of alternative agents has not been validated."
Moisture and corrosion "Ensure the device is thoroughly dried before storage. Retained moisture may cause corrosion or microbial growth."

Usability Validation of IFU Instructions

FDA's 2015 guidance recommends that manufacturers validate that users can understand and follow the reprocessing instructions. This is effectively a human factors study for the IFU.

Usability Validation Approach

Step Activity
1. Formative evaluation Have representative users (SPD technicians) attempt to follow draft IFU; observe and document errors, confusion, and deviations
2. Revision Revise IFU based on formative findings — add illustrations, clarify ambiguous steps, reorganize sequence
3. Summative evaluation Have a new set of representative users follow the revised IFU under observation; record whether they correctly complete all steps
4. Analysis Document all use errors and near-misses; assess whether errors are IFU-related or user-related
5. Final revision Address any remaining IFU-related errors; document rationale for accepted residual risk

ISO 20417:2026 Readability Requirements

The 2026 update to ISO 20417 introduces measurable readability expectations for IFUs:

  • "Readily understood" is no longer sufficient as a qualitative claim. Lay-user IFUs must be tested and documented to a defined education level.
  • Readability scoring: Use validated tools such as Flesch-Kincaid or SMOG; target grade 7–8 equivalent as a benchmark.
  • Plain-language review: Have the IFU reviewed by someone without a technical background.
  • Documentation: Record the methodology, results, and iterations made to the IFU as a result of readability testing.
Recommended Reading
Clinical Evaluation Report Template: EU MDR CER Structure, Tables, and Evidence Traceability
Clinical Evidence EU MDR / IVDR2026-04-30 · 18 min read

IFU Content Checklist: Audit-Ready Template

Use this checklist to verify completeness before submission or audit.

# IFU Element Present? Validated? Location in IFU
1 Device identification (name, model, catalog number) N/A
2 Intended reprocessing life (max cycles) ☐ End-of-life testing
3 Point-of-use treatment instructions ☐ Cleaning validation
4 Disassembly instructions with diagrams ☐ Usability validation
5 Preparation for cleaning (pre-rinse, soaking) ☐ Cleaning validation
6 Manual cleaning procedure (detergent, water, brushing, rinsing) ☐ Cleaning validation (ST98)
7 Automated cleaning procedure (WD cycle, detergent, loading) ☐ Cleaning validation + ISO 15883
8 Visual inspection criteria and method ☐ Cleaning validation
9 Disinfection method and parameters ☐ Disinfection validation
10 Sterilization method and parameters ☐ Sterilization validation
11 Packaging instructions for sterilization ☐ Packaging validation
12 Drying instructions and duration ☐ Validation
13 Storage conditions and shelf life ☐ Stability/aging data
14 Functional check before reuse ☐ End-of-life testing
15 Reuse life tracking method N/A
16 Disposal instructions N/A
17 Warnings and precautions ☐ Risk management file
18 PPE requirements for reprocessing personnel N/A
19 Contact information for questions N/A
20 Applicable standards referenced N/A

Submission Evidence Mapping

Submission Document IFU Evidence Required
510(k) Complete proposed labeling including reprocessing IFU; validation summary or full report per Appendix E of FDA guidance
PMA Full reprocessing validation protocol and test report; IFU usability validation report
De Novo Same as PMA
EU MDR Technical File (Annex II) Full IFU; reprocessing validation reports; risk management file linking IFU content to risk controls
Design History File IFU design inputs, outputs, verification records, usability testing records

FDA Appendix E devices (for which 510(k) must contain data to validate reprocessing instructions) include:

  • Endoscopes and accessories
  • Laparoscopic instruments and accessories
  • Arthroscopic instruments and accessories
  • Devices with lumens
  • Devices with hinges or moving parts
  • Ultrasonic surgical aspirators
  • Phacoemulsification devices

Common Audit Findings and How to Prevent Them

Audit Finding Root Cause Prevention
IFU references unavailable agents Detergent/disinfectant not available in target market Verify agent availability; list alternatives with validation support
Missing maximum reprocessing cycles Not tested or not stated Include validated cycle limit; support with end-of-life data
No usability validation of IFU Assumed clarity without testing Conduct formative and summative evaluations per FDA guidance
Cleaning validation does not match IFU Protocol used different parameters than IFU text Side-by-side comparison of IFU text and validation protocol
No point-of-use treatment section Omitted as "not necessary" Include even if brief; regulators expect to see it addressed
Missing diagrams for disassembly Text-only instructions for complex devices Add numbered step-by-step diagrams with labeled components
IFU not in required language(s) Overlooked EU language requirements ISO 17664 requires IFU in accepted languages of member states where sold
eIFU non-compliant with EU MDR Missing paper backup option or URL stability Implement (EU) 2025/1234 requirements; register in EUDAMED by May 2026
Recommended Reading
Washer-Disinfector Validation for Medical Devices: ISO 15883, Thermal Disinfection, Process Parameters, and Routine Monitoring
Quality Systems Regulatory2026-04-30 · 14 min read

Electronic IFU (eIFU) Considerations

Under EU MDR and Implementing Regulation (EU) 2025/1234 (effective for 2026):

Requirement Detail
Scope expansion Nearly all professionally used devices may use eIFU without printed manuals, based on risk assessment
Mandatory paper option Printed IFU must be available free of charge, supplied within 7 days upon request
Lay-user devices Home-use and consumer devices must still include printed IFU by default
Persistent URLs Packaging must include stable link to eIFU; link must remain accessible for device lifecycle
EUDAMED registration By May 28, 2026, manufacturers must register UDI and eIFU links in EUDAMED
Version control Complete archive of all prior IFU versions with traceability, timestamps, and change history

Key Takeaways

  • Reprocessing IFUs must follow a six-section structure: identification, point-of-use treatment, preparation, cleaning, disinfection/sterilization, and storage/reuse
  • Every instruction must be validated — the IFU text must match the validation protocol parameters exactly
  • FDA expects IFU usability validation — a human-factors-like study confirming that users can follow the instructions
  • ISO 20417:2026 introduces measurable readability requirements — qualitative "readily understood" claims are no longer sufficient
  • Warnings and precautions must address foreseeable misuse, supported by the risk management file
  • Point-of-use treatment is expected even for simple devices; omitting it is a common audit finding
  • eIFU compliance in the EU requires EUDAMED registration by May 2026 and persistent URL management
  • Use the audit-ready checklist above to verify completeness before every submission

Sources

  • ISO 17664-1:2021 — Processing of health care products, Part 1: Critical and semi-critical medical devices
  • ISO 17664-2:2021 — Processing of health care products, Part 2: Non-critical medical devices
  • FDA Guidance — Reprocessing Medical Devices in Health Care Settings: Validation Methods and Labeling (March 2015)
  • ISO 20417:2026 — Medical device labeling requirements
  • ANSI/AAMI ST98:2022 — Cleaning validation of health care products
  • Implementing Regulation (EU) 2025/1234 — Electronic instructions for use
  • Emergo by UL — US FDA Reprocessing Expectations (March 2026)
  • Test Labs UK — Medical Device Reprocessing Instructions Development
  • DDISmart — Electronic Instructions for Use (eIFU): The Complete 2026 Guide
  • TÜV SÜD — Reprocessing Validation for Reusable Medical Devices (whitepaper)
  • Nelson Labs — Comments on Reprocessing Guidance for Industry and FDA Staff (March 2015)
  • MDX CRO — ISO 20417:2026: Medical Device Labelling Requirements